Discussion about this post

User's avatar
Neural Foundry's avatar

Brillant breakdown of the GLP-1 factor, which honestly doesn't get enough attention in food industry analysis. The way these meds are basically reshaping people's cravings away form high-fat stuff is gonna be wild for any volume-based business. I've seen friends on Ozempic literally skip pizza nights because the though of heavy food just doesn't appeal anymore. Really solid insight on how Vermont's artisan approach might actually be better positioned than chains for this shift.

No posts

Ready for more?